`
Thursday, 29 June 2017

Japan News

  • Infraredx to launch TVC Imaging System in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2012

    Singapore: Infraredx, a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, has signed an exclusive five-year agreemen...Read more

  • Mantra of Interphex Japan & in-Pharma Japan: Lets innovate and focus on emerging markets

    Japan |  Analysis | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013

    The 7th in-Pharma Japan and 26th Interphex Japan, both of which were held concurrently at Tokyo Big Sight, Japan, from July 10-12, 2013, concluded with much success and grandeur. The event ...Read more

  • Mitsubishi Tanabe to manufacture diabetes drug Tenelia

    Japan |  Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012

    Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibitor Tenelia 20mg tablets (Teneligliptin hydrobromide hydrate) in Japa...Read more

  • Otsuka expands collaboration with Lundbeck

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013

    Singapore: Japanese company Otsuka Pharmaceutical and H Lundbeck, Denmark-based company, have outlined co-promotion plans and summarized the overall progress in their global alliance at a s...Read more

  • Novartis' Alcon recalling more intraocular lenses in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Dec, 2015

    Singapore: Novartis' Alcon expanded the recall of its intraocular lenses in Japan, pushing the number of affected units to 89,042, due to a continued increase in reports of postoperative in...Read more

  • Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2016

    Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the next decade, rising from approximately $640 million in 2014 to over $2....Read more

  • Eisai enters license agreement with HUYA Bioscience

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Feb, 2016

    Singapore: Eisai has entered into an exclusive license agreement with HUYA Bioscience International to develop and market the oral histone deacetylase (HDAC) inhibitor HBI-8000 in Japan, So...Read more

  • Eisai receives positive CHMP opinion on new indication for anticancer agent

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2016

    Singapore: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received a positive opinion from the European Medicines Agency's Committee for Medicinal P...Read more

  • St. Jude launches cardiac resynchronization therapy defibrillator

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2012

    Singapore: St. Jude Medical, a global medical device company, has launched the Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) in Japan. The Unify Quadra CRT-D works wi...Read more

  • Mallinckrodt's pharmaceutical gas approved in Australia and Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015

    Tokyo: United Kingdom's Mallinckrodt plc has announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conju...Read more

  • Thailand, Japan to develop medical robots

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2015

    Singapore: Thailand Center of Excellence for lifesciences has signed a pact with Mahidol University's Faculty of Engineering, Japan's Economy, Trade and Industry Ministry, Mitsubishi Resear...Read more

  • NDA approval for obesity drug Oblean in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013

    Singapore: Netherlands-based Norgine BV and Japanese drugmaker Takeda Pharmaceutical have announced the approval of the New Drug Application (NDA) for Oblean (cetilistat) Tablets 120mg for ...Read more

  • Japan's PeptiDream partners with Genentech

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015

    Singapore: PeptiDream, Tokyo-based biopharmaceutical company, has entered into a multi-target discovery and optimization collaboration with US-based Genentech, a member of the Roche Group. ...Read more

  • Daiichi Sankyo files NDA for Prasugrel in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013

    Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welfare in Japan for the antiplatelet agent Prasugrel for the treatment o...Read more

  • Shimadzu Global Pharma Summit gathers veterans to share regulatory challenges

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2016

    Singapore: 5th Shimadzu Global Pharma Summit 2015, the flagship event of Shimadzu that provides a platform for the global pharma industry to network, share and discuss strategies for the fu...Read more

  • Eisai buys Chinese Generics Company Liaoning TianYi

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2016

    Singapore: Eisai announced that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical previously announced on November 27, 2015, the ...Read more

  • HMT opens office in US

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2012

    Singapore: Human Metabolome Technologies (HMT), the leading provider of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technology, announced the opening of its firs...Read more

  • Aricept leads Japan pharma market with $1.81 bn

    Japan |  Analysis | By Narayan Kulkarni | 0 Comment | 12 Jun, 2012

    The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent of the $120 billion pharmaceutical market, says an IM...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls